Advised Therapure Biopharma Inc., a Canada-based contract manufacturing and drug development company engaged in developing, manufacturing, purifying and packaging of therapeutic proteins and biosimilars for biopharmaceutical companies, in its sale of its contract development and manufacturing business to 3SBio Inc. and CITIC Private Equity Funds Management Co Ltd. 3SBio Inc. is a listed China-based company engaged in the research, development, manufacture and marketing of biopharmaceutical products, headquartered in Shenyang. CITIC Private Equity Funds Management Co Ltd is a China-based private equity and venture capital firm, headquartered in Beijing.
Mandats représentatifs
Catalyst Capital Group US$290 million sale of its portfolio company, Therapure Biopharma
Fasken
Temps de lecture
1 minutes
Aperçu
Aperçu
Équipe
Équipe
- Jon Levin, Associé, Toronto, ON, +1 416 865 4401, jlevin@fasken.com
- Doug H. Scott, Associé, Toronto, ON, +1 416 943 8823, dhscott@fasken.com
- Laura Fetter, Avocate-conseil | de l'nnovation, Toronto, ON, +1 416 865 4450, lfetter@fasken.com
- Clifford Sosnow, Associé, Toronto, ON | Ottawa, ON, +1 613 696 6876, csosnow@fasken.com
- Daniel R. Law, Associé, Toronto, ON, +1 416 868 3479, dlaw@fasken.com
- Huy Do, Associé, Toronto, ON, +1 416 868 3505, hdo@fasken.com
- Christopher Steeves, Associé, Toronto, ON, +1 416 868 3401, csteeves@fasken.com
- Paul V. Casuccio, Associé, Toronto, ON, +1 416 868 3491, pcasuccio@fasken.com
- Ingrid E. VanderElst, PhD, Associée | Agente de marques de commerce, Toronto, ON, +1 416 865 4519, ivanderelst@fasken.com
